Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000016

Chief Medical Officer sold 4,087 shares at an average $28.52 ($116,568)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-05 Sale : show line 1 in the form −2,636 $28.44 $74,968 180,364 I
2023-01-06 Sale : show line 2 in the form −1,451 $28.67 $41,600 178,913 I
Open-market sales · 4,087 sh · avg $28.52 · $116,568
Loading xslF345X03/wf-form4_167331860319501.xml…